Richard C White
Overview
Explore the profile of Richard C White including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White R, Kovacs G, Chandran S, Adams P, Britson K, Cao H, et al.
Health Secur
. 2025 Jan;
23(1):47-54.
PMID: 39882823
The COVID-19 pandemic has revealed the need for nations to prepare more effectively for emerging infectious diseases. Preparing for these threats requires a multifaceted approach that includes assessing pathogen threat,...
2.
Boonyasiri A, Brinkac L, Jauneikaite E, White R, Greco C, Seenama C, et al.
BMC Infect Dis
. 2023 Aug;
23(1):556.
PMID: 37641085
Background: Colistin is one of the last resort therapeutic options for treating carbapenemase-producing Enterobacterales, which are resistant to a broad range of beta-lactam antibiotics. However, the increased use of colistin...
3.
Johnson R, White R, Disbrow G
Hum Vaccin Immunother
. 2022 Oct;
18(6):2129930.
PMID: 36302122
The COVID-19 pandemic profoundly disrupted, and, out of necessity, accelerated innovation of research and development of medical countermeasures to combat COVID-19. Although countermeasures were developed with unprecedented speed as a...
4.
Hujer A, Bethel C, Taracila M, Marshall S, Rojas L, Winkler M, et al.
Antimicrob Agents Chemother
. 2022 Apr;
66(5):e0179021.
PMID: 35435707
Multidrug-resistant (MDR) Pseudomonas aeruginosa infections are a major clinical challenge. Many isolates are carbapenem resistant, which severely limits treatment options; thus, novel therapeutic combinations, such as imipenem-relebactam (IMI/REL), ceftazidime-avibactam (CAZ/AVI),...
5.
Grigoryeva L, Rehman S, White R, Garnett J, Cianciotto N
Bio Protoc
. 2021 Apr;
11(5):e3933.
PMID: 33796607
, a Gram-negative bacterium and the causative agent of Legionnaires' disease, exports over 300 effector proteins/virulence factors, through its type II (T2SS) and type IV secretion systems (T4SS). One such...
6.
Chan A, Choi Y, Clarke T, Brinkac L, White R, Jacobs M, et al.
J Antimicrob Chemother
. 2020 Jul;
75(10):2760-2768.
PMID: 32681170
Objectives: To investigate the genomic context of a novel resistance island (RI) in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates and global isolates. Methods: Using a combination of long and short...
7.
Portlock T, Tyson J, Dantu S, Rehman S, White R, McIntire I, et al.
Front Mol Biosci
. 2020 Jul;
7:112.
PMID: 32656228
is a Gram-negative bacterium that is able to replicate within a broad range of aquatic protozoan hosts. is also an opportunistic human pathogen that can infect macrophages and epithelia in...
8.
Rehman S, Grigoryeva L, Richardson K, Corsini P, White R, Shaw R, et al.
PLoS Pathog
. 2020 May;
16(5):e1008342.
PMID: 32365117
Chitinases are important enzymes that contribute to the generation of carbon and nitrogen from chitin, a long chain polymer of N-acetylglucosamine that is abundant in insects, fungi, invertebrates and fish....
9.
DSouza R, White R, Buzzeo R, Goglin K, Vashee S, Lee Y, et al.
Microbiol Resour Announc
. 2020 Apr;
9(16).
PMID: 32299871
Antibiotic-resistant is an opportunistic pathogen causing serious human infections worldwide. Here, we report the complete annotated genome of bacteriophage SA75, a member of the family which could be an alternative...
10.
Jacobs M, Good C, Hujer A, Abdelhamed A, Rhoads D, Hujer K, et al.
Antimicrob Agents Chemother
. 2020 Mar;
64(5).
PMID: 32152078
Plazomicin was tested against 697 recently acquired carbapenem-resistant isolates from the Great Lakes region of the United States. Plazomicin MIC and MIC values were 0.25 and 1 mg/liter, respectively; 680...